Drugs
(XML - 5KB)Current Drug Shortages L - N
The information provided in this section is provided voluntarily by manufacturers. FDA cannot require firms to report the reason for shortage or duration of the shortage or any other information about shortages. FDA appreciates all information provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers. To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov. Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.
*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012
Leucovorin Calcium Lyophilized Powder for Injection
** Please note Levoleucovorin (Fusilev) is available in ample quantities**There is potential for dosing errors when interchanging leucovorin and levoleucovorin (Fusilev). The dose of levoleucovorin (Fusilev) is one-half the dose of racemic leucovorin injection (e.g., levoleucovorin [Fusilev] 7.5 mg = racemic leucovorin 15 mg). For more information visit: Spectrum Pharmaceuticals web site.
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Bedford Laboratories | 50 mg (NDC 55390-0005-10) | Bedford laboratories has 50mg, 100mg, and 350 mg powder for injection available in limited quantities. Once this supply is depleted the next estimated release dates are unknown. Availability of products is updated on the Bedford Laboratories website. | The 50 mg/50 mL solution and 200 mg powder for injection are pending release with release date yet to be determines. Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | Revised 4/10/2012 |
| 100 mg (NDC 55390-0052-10) | |||||
| 200 mg (NDC 55390-0053-01) | |||||
| 350mg (NDC 55390-0054-01) | |||||
| 500mg 50mL solution (NDC 55390-0009-01) | |||||
| Teva Pharmaceuticals 1-800-545-8800 | 100mg/vial (NDC 0703-5140-01) 20mL | Teva, in conjunction with the FDA, is initiating a temporary importation of Leucovorin Calcium Folinate Solution for Injection, to the United States market to address the current shortage. | See Dear Healthcare Professional letter (PDF 692KB) for additional information. | Regulatory delay. | Revised 10/18/2012 |
| 350mg/vial (NDC 00703-5145-01) 30mL | |||||
| APP Pharmaceuticals 1-888-386-1300 | 200 mg SDV (NDC 63323-710-50) | APP is currently back-ordered due to increased demand. Intermittent releases are being allocated. | Shortage per Manufacturer: Increased demand | Demand increase for the drug. | Reverified 9/10/2012 |
| 500 mg SDV (NDC 63323-711-00) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Teva 1-800-545-8800 | 1 mg/0.2 ml (NDC 00703-4014-18) | Teva has Leuprolide Injection on backorder. Teva anticipates product availability in Q213 | Requirements related to complying with good manufacturing practices | Revised 10/18/2012 | |
| Sandoz 1-609-627-8500 | 1 mg/0.2 ml (NDC 00185-7400-85) | Estimate available 4Q2012. | Product currently unavailable. Manufacturing site availability, we will continue to provide updates as further information becomes available. | Other | Reverified 10/1/2012 |
| Caraco 313-871-8400 | 1 mg/0.2 ml (NDC 41616-0936-40) | On intermittent backorder. | Shortage per Manufacturer: Increase in demand | Demand increase for the drug. |
Lidocaine Hydrochloride Injection (Initial Posting Date) - 2/22/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP Customer Service: 1-888-386-1300 | Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57) | Check Wholesalers for Inventory | All lidocaine and Xylocaine presentations are on intermittent back order and will be released as the product becomes available. Shortage per Manufacturer: | Demand increase for the drug. | Reverified 10/3/2012 |
| Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57) | |||||
| Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02 | |||||
| Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10) | |||||
| Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27) | |||||
| Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37) | |||||
| Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31) | |||||
| Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97) | |||||
| Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91) | |||||
| Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02) | |||||
| Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05) | |||||
| Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17) | |||||
| Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27) | |||||
| Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57) | |||||
| Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10) | |||||
| Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued | |||||
| Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50) – NDC discontinued | |||||
| Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27) | |||||
| Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07) | |||||
| Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97) | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.5% w/EPI 1:200,000; 50 mL vial (NDC 0409-3177-01) | Next delivery October Estimated recovery: 2Q 2013 | Please check with your wholesaler for available inventory.
Shortage of Manufacturer: manufacturing delay | Other | Revised 10/23/2012 |
| 1% w/EPI 1:100,000; 20 mL vial (NDC 0409-3178-01) | Next delivery November Estimated recovery: 2Q 2013 | ||||
| 1% w/EPI 1:100,000; 30 mL vial (NDC 0409-3178-02) | Next delivery October Estimated recover 1Q 2013 | ||||
| 1% w/EPI 1:100,000; 50 mL vial (NDC 0409-3178-03) | Next delivery October Estimated recovery: 2Q 2013 | ||||
| 1.5% w/EPI 1:200,000; 5 mL amp (NDC 0409-1209-01) | Available | ||||
| 1.5% w/EPI 1:200,000; 5 mL amp (NDC 0409-1209-65) | Available | ||||
| 1.5% w/EPI 1:200,000; 30 mL amp (NDC 0409-3181-01) | Next delivery December Estimated recovery 2Q 2013 | ||||
| 2% w/EPI 1:100,000; 20 mL vial (NDC 0409-3182-01) | Next delivery November Estimated recovery 1Q 2013 | ||||
| 2% w/EPI 1:100,000; 30 mL vial (NDC 0409-3182-02) | Next delivery October Estimated recovery 1Q 2013 | ||||
| 2% w/EPI 1:100,000; 50 mL vial (NDC 0409-3182-03) | Next delivery December Estimated recovery December | ||||
| 2% w/EPI 1:200,000; 20 mL vial (NDC 0409-3183-01) | Available | ||||
| .0.5%; 50 mL FT vial (NDC 0409-4275-01) | Next delivery November Estimated recovery: 1Q 2013 | ||||
| 0.5%; 50 mL TT vial (NDC 0409-4278-01) | Next delivery December Estimated recovery 2Q 2013 | ||||
| 1%; 2 mL amp (NDC 0409-4713-32) | Available | ||||
| 1%; 20 mL vial (NDC 0409-4276-01) | Next delivery October Estimated recovery: December | ||||
| 1%; 30 mL vial (NDC 0409-4279-02) | Next delivery October Estimated recovery: December | ||||
| 1%; 50 mL vial (NDC 0409-4276-02) | Available | ||||
| 1%; 30 mL Sterile Pack vial (NDC 0409-4270-01) | Next delivery November Estimated recovery December | ||||
| 2%; 2 mL amp (NDC 0409-4282-01) | Next delivery November Estimated recovery: 2Q 2013 | ||||
| 2%; 10 mL amp (NDC 0409-4282-02) | Available | ||||
1%; 5 mL Abboject syringe (NDC 0409-4904-34) | Next delivery November Estimated recovery: December | ||||
2%; 5 mL Abboject syringe (NDC 0409-4903-34) | Next delivery December Estimated recovery: 2Q 2013 | ||||
| 2%; 5 mL vial (NDC 0409-2066-05) | Available | ||||
| 2%; 20 mL vial (NDC 0409-4277-01) | Available | ||||
| 2%; 50 mL vial (NDC 0409-4277-02) | Available | ||||
| 4%; 5 mL amp (NDC 0409-4283-01) | Available | ||||
| Product 1.5% w/EPI 1:200,000; 5 mL amp (NDC 0409-1209-65) | Available | ||||
| 2%; 5mL Ansyr syringe (NDC 0409-1323-05) | Next delivery October Estimated recovery: 2Q 2013 | ||||
| Amphastar Pharmaceuticals, Inc. Customer Service: 1-800-423-4136 | 2%, 5mL Luer-Jet Prefilled Syringe NDC 76329-3390-1 (old NDC 0548-3390-00) | Amphastar will regularly release products. | Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues. Shortage per Manufacturer: | Demand increase for the drug. | Reverified 9/24/2012 |
| American Regent/Luitpold 1-800-645-1706 | 1%, 50 mL vial package of 25 (NDC 00517-0625-25) | Unavailable | Shortage per Manufacturer: American Regent/Luitpold is not manufacturing Lidocaine HCl Injection, USP | Discontinuation of the manufacture of the drug | Reverified 10/17/2012 |
| 2%, 50 mL vial package of 25 (NDC 00517-0626-25) |
Lidocaine HCL, 4% Topical Solution (Initial posting– 5/31/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | LTA Kit; 4 mL syringe kit (NDC 0409-4698-01) | Next delivery November Estimated recovery 4Q 2012 | Please check with your wholesaler for available inventory.
Shortage per Maufacturer: manufacturing delay | Other | Revised 10/12/2012 |
| Amphastar Pharmaceuticals, Inc. Customer Service: 1-800-423-4136 | 4mL Laryng-O-Jet, NDC 76329-6300-5 (old NDC 0548-6300-00) | Amphastar will regularly release products. | Shortage per manufacturer: Increase in product demand caused by market supply issues. | Demand increase for the drug. | Revised 9/24/2012 |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
West-Ward Pharmaceuticals | 2 mg/mL, 1 mL vial | West-Ward has accelerated production on all codes and is projecting to have additional inventory available for release in the July - August 2012 timeframe. Product will be made available as it is released. | Shortage per Manufacturer: | Demand increase for the drug | Revised-7/9/2012 |
2 mg/mL, 10 mL vial | Available in very limited quantities |
| |||
4 mg/mL, 1 mL vial | Backordered |
| |||
4 mg/mL, 10 mL vial, | Available in very limited quantities |
| |||
2 mg/mL, 1 mL vial | Backordered |
| |||
2 mg/mL, 10 mL vial, | Available in very limited quantities |
| |||
4 mg/mL, 1 mL vial | Available in very limited quantities |
| |||
4 mg/mL, 10 mL vial, | Available in very limited quantities |
| |||
Bedford Laboratories Customer Service: | 2 mg/mL, 1 mL vial (NDC 55390-0168-10), 10 mL vial (NDC 55390-0170-10) | Product Discontinued: Bedford currently has all presentations discontinued. | Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. |
|
Hospira Inc. Customer Service: | 2 mg/mL; 1 mL vial | Next delivery October Estimated: 1Q 2013 | Please check with your wholesaler for available inventory.
Shortage per Manufacturer:
| Other | Revised 10/12/2012 |
2 mg/mL; 10 mL vial | Available | ||||
2 mg/mL; 1 mL Carpuject syringe | Available | ||||
2 mg/mL; 1 mL iSecure syringe | Discontinued | ||||
4 mg/mL; 1 mL vial | Next delivery December | ||||
4 mg/mL; 10 mL vial | Next delivery December | ||||
4 mg/mL; 1 mL | Temporarily unavailable | ||||
Akorn Pharmaceutical: | 2 mg/mL, 1 mL vial | Readily available |
| Revised 9/25/2012 |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
APP: 1-888-386-1300 | 500 mg/mL, 2 mL vial (NDC 63323-0064-02) | Available | Check wholesalers for inventory. All other presentations are on intermittent back-order and the company is releasing product as it becomes available. Shortage per Manufacturer: | Demand increase for the drug. | Revised 10/19/2012 |
| 500 mg/mL, 10 mL vial (NDC 63323-0064-10) | Currently back-ordered. Next delivery expected December 2012 | ||||
| 500 mg/mL, 20 mL vial (NDC 63323-0064-20) | Back-ordered. Next delivery late October | ||||
| 500 mg/mL, 50 mL vial (NDC 63323-0064-50) | Currently back-ordered. Next delivery expected late October. | ||||
| American Regent/Luitpold 1-800-645-1706 | 500 mg/mL, 2 mL vial (NDC 00517-2602-25) | Unavailable | Currently not releasing. | Other | Reverified 10/17/2012 |
| 500 mg/mL, 10 mL vial (NDC 00517-2610-25) | |||||
| 500 mg/mL, 50 mL vial (NDC 00517-2650-25) | |||||
| Hospira, Inc. Customer Service 1-877-946-7747
| 50%; 20 mL vial (NDC 0409-2168-02) | Next delivery and estimated recovery 1Q 2013 | Please check with your wholesaler for available inventory.
Shortages per Manufacturer: manufacturing delay | Other and shortage of an active ingredient (NDC 0409-6790-13). | Reverified 10/12/2012 |
50 %; 10 mL Ansyr syringe (NDC 0409-1754-10) | Next delivery and estimated recovery 1Q 2013 | ||||
40 mg/mL-water; 50 mL bag (NDC 0409-6729-24) | Available | ||||
40 mg/mL-water; 100 mL bag (NDC 0409-6729-23) | Available | ||||
40 mg/mL-water; 500 mL bag (NDC 0409-6729-03) | Available | ||||
40 mg/mL-water; 1000 mL bag (NDC 0409-6729-09) | Available | ||||
10 mg/mL-dextrose; 100 mL bag (NDC 0409-6727-23) | Available | ||||
80 mg/mL-water; 50 mL bag (NDC 0409-6730-13) | Next delivery and estimated recovery Q4 2012 |
Mannitol Injection (Initial Posting Date) - 12/21/2011
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP Customer Service: 1-888-386-1300 | 250 mg/mL, 50 mL vial, 25 count (NDC 63323-0024-25) | Check wholesalers for Inventory. Next delivery anticipated late November 2012. | APP has increased production and will have intermittent releases of product. Shortage per Manufacturer: | Demand increase for the drug. | Revised 10/3/2012 |
| B. Braun Medical Inc. Customer Service: 1-800-227-2862 | 20% Mannitol Injection USP 500 mL flexible plastic container NDC 0264-7578-10 | All presentations available. |
| Revised 10/17/2012 | |
| 250 mL flexible plastic container NDC 0264-7578-20 | |||||
| Hospira, Inc. Customer Service 1-877-946-7747 | 25%; 50 mL vial (NDC 0409-4031-01) | Next delivery November Estimated recovery: 1Q 2013 | Please check with your wholesaler for all available inventory. Shortage per Manufacturer: | Other | Revised 9/28/2012 |
| 20%; 250 mL container (NDC 0409-7715-02) | Temporarily unavailable | ||||
| 20%; 500 mL container (NDC 0409-7715-03) | Temporarily unavailable | ||||
| American Regent/Luitpold 1-800-645-1760 | 25%, 50 mL vial NDC 0517-4050-25 | Unavailable | Currently not releasing. | Other | Reverified 10/17/2012 |
| Baxter Customer Service: 1-800-ANA-DRUG (1-800-262-3784) | 20% OSMITROL Injection (20% Mannitol Injection, USP). NDC: 0338-0357-02 | Available | Shortage per Manufacturer: Product Available | Other | Reverified 9/24/2012 |
| 20% OSMITROL Injection (20% Mannitol Injection, USP). NDC: 0338-0357-03 |
Methazolamide Tablets (Initial posting – 6/29/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Sandoz Customer Service: | 25 mg, 100s (NDC 0781-1072-01) | Product is currently on backorder. Expected shortage through 2012. | Shortage of an active ingredient | Revised 10/1/2012 | |
25 mg, 1000s (NDC 0781-1072-10) | |||||
50 mg, 100s (NDC 0781-1071-01) | |||||
50 mg, 1000s (NDC 0781-1071-10) | |||||
Fera Pharmaceuticals Customer Service | 25 mg, 100s (NDC 48102-0100-01) | Ample supply to meet the national market demand. | Shortage per Manufacturer: Available | Other | |
50 mg, 100s (NDC 48102-0101-01) | |||||
Neptazane- 25 mg, 90s (NDC 48102-0014-90) | |||||
Neptazane- 50 mg, 90s (NDC 48102-0015-90) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
APP Customer Service
| 25 mg/mL; 10 mL vial (NDC 63323-0123-10) | Available | Please check wholesalers for inventory Shortage per Manufacturer: | Demand increase for the drug. | Reverified 10/3/2012 |
1 g, SDV, Lyo (NDC 63323-0122-50) | Available | ||||
Bedford Customer Service 1-800-562-4797 | 25 mg/mL; 2 mL vial; Preservative Free |
| Bedford Laboratories has preservative-free 1 gram lyophilized powder for injection (NDC 55390-0143-01) available in limited quantities.. Once this supply is depleted, the next estimated release dates are unknown. Other presentations are out of stock and the company cannot estimate a release date. Production is pending as capacity permits. Availability of products is updated on the Bedford Laboratories website. Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | Revised 4/10/2012 |
25 mg/mL; 4 mL vial; Preservative Free | |||||
25 mg/mL; 8 mL vial; Preservative Free | |||||
25 mg/mL; 10 mL vial; Preservative Free | |||||
Methotrexate lyophilized powder for injection | |||||
Hospira, Inc. Customer Service | 25 mg/mL; 2 mL vial | Available | Please check with your wholesaler for all available inventory. | Demand increase for the drug | Reverified 10/12/2012 |
25 mg/mL; 40 mL vial; | Available | ||||
Mylan Institutional | 25mg/mL; 2mL vial | 2 mL and 10 mL vials on allocation. Please check with your wholesaler for availability. | Demand increase for the drug. | Reverified 9/27/2012 | |
25mg/mL; 10mL vial | |||||
25mg/mL; 40mL vial | 40 mL vial currently unavailable | ||||
Sandoz Customer Service: | 25mg/ml; 2ml vial | Temporarily discontinued the 2ml vial presentation. | Shortage per Manufacturer: | Discontinuation of the manufacture of the drug | Reverified 10/1/2012 |
25mg/ml; 10ml vial | Temporarily discontinued the 10 mL vial presentation | ||||
25mg/ml; 40ml vial | Experiencing a back order on 40ml vials. | ||||
Teva: | 25mg/ml; 2mL vial Preservative Free (NDC 00703-3671-03) | All presentation are available with ample inventory. | Teva launched this product on July 31, 2012.
| Demand increase for the drug. | Reverified 10/18/2012 |
| |||||
25mg/ml; 10mL vial Preservative Free (NDC 00703-3675-01) | |||||
| 25mg/mL; 40mL vial Preservative Free (NDC 00703-3678-01) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| American Regent, Inc./Luitpold: 1-800-645-1706 | 50 mg/mL, 5 mL vial (NDC 00517-8905-10) | Unavailable | Currently not releasing. | Other | Reverified 10/17/2012 |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 5 mg/mL 2 mL vials (NDC 00409-3414-01) | Next delivery October/Estimated recovery 1Q 2013 | Please check with your wholesaler for available inventory. | Demand increase for the drug. | Reverified 10/12/2012 |
| Teva Pharmaceuticals 1-800-545-8800 | 5 mg/mL, 2 mL vial, 25 count (NDC 00703-4502-04) | Not available | Teva has made a business decision to discontinue this product. See the Dear Valued Customer Letter (PDF - 32KB) | Discontinuation of the manufacture of the drug. | Reverified 10/18/2012 |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 1 mg/mL, 2 mL vial, 25 count (NDC 63323-0411-12) | APP has midazolam injection on intermittent back order and the company is releasing product on a regular basis. | Check with wholesalers for inventory. Shortage per Manufacturer: | Demand increase for the drug. | Reverified 10/3/2012 |
| 1 mg/mL, 5 mL vial, 25 count (NDC 63323-0411-25) | |||||
| 1 mg/mL, 10 mL vial, 10 count (NDC 63323-0411-10) | |||||
| 5 mg/mL, 5 mL vial, 10 count (NDC 63323-0412-05) | |||||
| 5 mg/mL, 10 mL vial, 10 count (NDC 63323-0412-10) | |||||
| 5 mg/mL, 2 mL vial, 25 count (NDC 63323-0412-02) | |||||
| 5 mg/mL, 1 mL fill in 2 mL vial, 25 count (NDC 63323-0412-25) | |||||
| Bedford Customer Service: 1-800-562-4797 | 1 mg/mL, 2 mL preservative-free vial, 10 count (NDC 55390-0137-02) | Bedford has all midazolam presentations on back order and the company cannot estimate a release date. | The 1 mg/mL 2 mL and 10 mL vials and the 5 mg/mL 2 mL (1 mL fill), 5 mL and 10 mL vials vials are pending release while the other presentations will not be manufactured until capacity permits.
Bedford Laboratories has temporarily suspended the distribution of Ben Venue Laboratories manufactured products. Availability of products is updated on the Bedford Laboratories website Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | |
| 1 mg/mL, 5 mL preservative-free vial, 10 count (NDC 55390-0137-05) | |||||
| 1 mg/mL, 10 mL vial, 10 count (NDC 55390-0125-10) | |||||
| 5 mg/mL, 2 mL preservative-free vial, 10 count (NDC 55390-0138-02) | |||||
| 5 mg/mL, 1 mL preservative-free, in 2 mL vial, 10 count (NDC 55390-0138-01) | |||||
| 5 mg/mL, 5 mL vial, 10 count (NDC 55390-0126-05) | |||||
| 5 mg/mL, 10 mL vial, 10 count (NDC 55390-0126-10)5 mg/mL, 10 mL vial, 10 count (NDC 55390-0126-10) | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1 mg/mL, 2 mL preservative-free Luer-lock syringe (NDC 0409-2306-62) | Available | Hospira discontinued the following products:
Shortage per Manufacturer: | Demand increase for the drug. | Reverified 10/12/2012 |
| 1 mg/mL, 2 mL preservative-free vial (NDC 0409-2305-17) | Available | ||||
| 1 mg/mL, 5 mL preservative-free vial (NDC 0409-2305-05) | Next delivery October/Estimated 1Q 2013 | ||||
| 1 mg/mL, 2 mL preservative-free iSecure syringe (NDC 0409-2306-12) | Available | ||||
| 1 mg/mL, 10 mL vial (NDC 0409-2587-05) | Available | ||||
| 5 mg/mL, 1 mL preservative-free vial (NDC 0409-2308-01) | Available | ||||
| 5 mg/mL, 5 mL vial (NDC 0409-2596-03) | Available | ||||
| 5 mg/mL, 10 mL vial (NDC 0409-2596-05) | Available | ||||
| 5 mg/mL, 1 mL preservative-free Luer-Lock syringe (NDC 0409-2307-60) | Next delivery 2013 | ||||
| 5 mg/mL, 2 mL preservative-free vial (NDC 0409-2308-02) | Next delivery October/Estimated recovery December | ||||
Sun Pharma USA (Caraco Pharmaceutical Laboratories, Ltd.) Customer Service: 1-800-818-4555 | 2mg/2mL (1mg/mL) NDC: 57664-0633-43, 10 pack | Readily Available | Product Available | Demand increase for the drug. | Posted 9/14/2012 |
| 25mg/5mL (5mg/mL) NDC: 57664-0634-44, 10 pack | |||||
| 50mg/10mL (5mg/mL) NDC: 57664-0634-45, 10 pack | |||||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 (Formerly a Baxter Product) | 2 mL vial, 1 mg/mL (NDC 0641-6057-25)25 pack (NDC 0641-6057-10)10 pack | West-Ward has accelerated production and will have units of all presentations available for release in the June – July 2012 timeframe. | West-Ward is currently experiencing a backorder situation on all of the Midazolam codes. Product will be made available as it is released. Shortage per Manufacturer: | Demand increase for the drug. | Revised 6/6/2012 |
5 mL vial, 1 mg/mL (NDC 0641-6059-10) | |||||
| 10 mL vial, 1 mg/mL (NDC 0641-6056-10) | |||||
1 mL vial, 5 mg/mL (NDC 0641-6061-25)25 pack(NDC 0641-6061-10)10 pack | |||||
2 mL vial, 5 mg/mL (NDC 0641-6063-25)25 pack (NDC 0641-6063-10)10 pack | |||||
10 mL vial, 5 mg/mL (NDC 0641-6060-10) | |||||
| Akorn: 1-800-932-5676 | 1 mg / mL; (2 mL x 10 pack) (NDC 17478-0523-02) | Readily available | Revised 9/25/2012 | ||
| 1 mg / mL; (5 mL x 25 pack) (NDC 17478-0523-55) | Readily available | ||||
| 1 mg / mL; (10 mL x 10 pack) (NDC 17478-0523-10) | Readily available | ||||
| 5 mg / mL; (1 mL x 10 pack) (NDC 17478-0524-01) | |||||
| 5 mg / mL; (2 mL x 10 pack) (NDC 17478-0524-02) | |||||
| 5 mg / mL; (5 mL x 10 pack) (NDC 17478-0524-05) | |||||
| 5 mg / mL; (10 mL x 10 pack) (NDC 17478-0524-10) | |||||
| Sagent Pharmaceuticals, Inc. 1-866-625-1618 | 2 mg/2 mL vial (preservative-free), NDC 25021-655-02 | Sagent has all presentations of midazolam on allocation. | Shortage per Manufacturer: Product Available | Demand increase for the drug. | Reverified 10/22/2012 |
| 5 mg/5 mL vial, (preservative-free) NDC 25021-655-05 | |||||
| 5 mg/mL vial, (preservative-free) NDC 25021-656-01 | |||||
| 10 mg/2 mL vial, (preservative-free) NDC 25021-656-02 | |||||
| 10 mg/10 mL vial, NDC 25021-660-10 | |||||
| 25 mg/5 mL vial, NDC 25021-661-05 | |||||
| 50 mg/10 mL vial, NDC 25021-661-10 |
Mitomycin Powder for Injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Accord Customer Service: 919-941-7879 | 5 mg (NDC 16729-0115-05) | Available at this time; Orders are being shipped out. | Demand increase for the drug. | Reverified 10/12/2012 | |
| 20 mg (NDC 16729-0108-11) | |||||
| 40 mg (NDC 16729-0116-38) | |||||
| Bedford Laboratories: 1-800-562-4797 | 5 mg (NDC 55390-0251-01) | Bedford Laboratories has 5 mg and 20 mg available in limited quantities. | Bedford Laboratories is out of stock and the company cannot estimate a release date. Production is pending as capacity permits. Availability of products is updated on the Bedford Laboratories website. Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | Revised 4/10/2012 |
| 20 mg (NDC 55390-0252-01) | |||||
| 40 mg (NDC 55390-0253-01) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1 mg/mL, 30 mL PCA vial (NDC 0409-2029-02) | Hospira is providing through direct customers only. Available | Please check with your wholesaler for available inventory.
Shortage per Manufacturer: | Other | Reverified 10/12/2012 |
| 5 mg/mL; 30 mL PCA vial (NDC 0409-6028-04) | Available | ||||
| 2 mg/mL; 1 mL Carpuject (NDC 0409-1762-30) | Product discontinued and replaced with new preservative free product (NDC 0409-1890-01) | ||||
| 4 mg/mL; 1 mL Carpuject (NDC 0409-1258-30) | Product discontinued and replaced with new preservative free product (NDC 0409-1891-01) | ||||
| 8 mg/mL; 1 mL Carpuject (NDC 0409-1260-69) | Product discontinued and replaced with new preservative free product (NDC 0409-1892-01) | ||||
| 10 mg/mL; 1 mL Carpuject (NDC 0409-1261-30) | Product discontinued and replaced with new preservative free product (NDC 0409-1893-01) | ||||
| 15 mg/mL; 1 mL Carpuject syringes (NDC 0409-1264-31) | Product discontinued and replaced with new preservative free product (NDC 0409-1894-01) | ||||
| 50 mg/mL, 20 mL vial (NDC 0409-1134-03) | Available | ||||
| 50 mg/mL, 50 mL vial (NDC 0409-1134-05) | Next delivery October Estimated recovery: 1Q 2013 | ||||
| 25 mg/mL; 4 mL Add-vantage vial (NDC 0409-6177-14) | Next delivery November Estimated recovery: 1Q 2013 | ||||
| 25 mg/mL, 10 mL Add-Vantage vial (NDC 0409-6179-14) | Next delivery November Estimated recovery: 1Q 2013 | ||||
| Amphastar Pharmaceuticals Inc. Customer Service: 1-800-423-4136 | 1mg/mL, 30mL PCA Vial (NDC 0548-1911-25) | Available | Other | Reverified 9/24/2012 | |
| West-Ward Customer Service: 1-888-229-0001 | 1 mL vial, 5 mg/mL (NDC 0641-6073-25) | Available in limited quantities | West-Ward has accelerated production on all Morphine codes and is projecting to have additional inventory available for release in the July – August 2012 timeframe. Product will be made available as it is released. Shortage per Manufacturer: | Demand increase for the drug. | Revised 7/9/2012 |
| 1 mL vial, 8 mg/mL (NDC 0641-6075-25) | Available in limited quantities | ||||
| 1 mL vial, 10 mg/mL) (NDC 0641-6070-25) | Available in limited quantities | ||||
| 10mL vial, 10 mg/mL (NDC 0641-6068-01) | Available in limited quantities | ||||
| 1 mL vial, 15 mg/mL (NDC 0641-6071-25) | Backordered | ||||
| 20 mL vial, 15 mg/mL (NDC 0641-6072-01) | Available in limited quantities | ||||
Morphine Sulfate Injection (Preservative Free)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 Astramorph (preservative-free) Inj | 0.5 mg/mL 2 mL ampule, 10 count (NDC 63323-0291-80) | APP has preservative-free Astramorph 0.5 mg/mL 2 mL ampules, 1 mg/mL 2 mL ampules and 10 mL ampules, and 0.5 mg/mL 10 mL vials on back order with an estimated release date in fourth quarter of 2012 | Shortage per Manufacturer: | Other | Reverified 10/3/2012 |
| 0.5 mg/mL 10 mL vial, 5 count (NDC 63323-0291-10) | |||||
| 1 mg/mL 2 mL ampule, 10 count (NDC 63323-0292-80) | |||||
| 1 mg/mL, 10 mL vial (NDC 63323-0292-10) | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.5 mg/mL; 10 mL vial (NDC 0409-3814-12) | Next delivery November Estimated recovery December |
| Other | Revised 10/23/2012 |
| 1 mg/mL; 10 mL vial (NDC 0409-3815-12) | Next delivery November Estimated recovery 1Q 2013 | ||||
25 mg/mL; 1 mL vial (NDC 0409-1135-02) | Available | ||||
| 2mg/mL; 1mL Carpuject (NDC0409-1890-01 | Next delivery October/Estimated recovery 4Q 2012 | New preservative-free product to replace preserved product NDC 0409-1762-30 | |||
| 4mg/mL; 1mL Carpuject (NDC 0409-1891-01) | Next delivery October/Estimated recovery 4Q 2012 | New preservative-free product to replace preserved product NDC 0409-1258-30 | |||
| 8mg/mL; 1mL Carpuject (NDC 0409-1892-01) | Next delivery November/Estimated recovery 4Q 2012 | New preservative-free product to replace preserved product NDC 0409-1260-69 | |||
| 10mg/mL; 1mL Carpuject (NDC 0409-1893-01) | Available | New preservative-free product to replace preserved product NDC 0409-1261-30 | |||
| 15mg/mL; 1mL Carpuject (NDC 0409-1894-01) | Available | New preservative-free product to replace preserved product NDC 0409-1264-31 | |||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 (Formerly a Baxter Product) | Infumorph | West-Ward currently has limited quantities available in all presentations. West-Ward has accelerated production on all Preservative-free Morphine codes and is projecting to have additional inventory available for release at the end of July 2012. | Product will be made available as it is released. Shortage per Manufacturer: | Demand increase for the drug. | Revised 7/9/2012 |
Infumorph | |||||
Duramorph | |||||
Duramorph |
Multi-Vitamin Infusion (Adult and pediatric)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira , Inc. Customer Service 1-877-946-7747 | MVI-12 Adult; 10 mL vial (NDC 61703-423-81) | Adult formulations: temporarily suspended production. | Shortage per Manufacturer: Adult formulations temporarily suspended production. | Discontinuation of the manufacture of the drug. | Reverified 10/12/2012 |
| MVI-12 Adult; 2x50 mL PBP(NDC 61703-423-83) | |||||
| MVI Adult; 10 mL vial (NDC 61703-422-81) | |||||
| MVI Adult; 2x5 mL (NDC 61703-422-82) | |||||
| MVI Adult 2x50 mL PBP (NDC 61703-422-83) | |||||
| MVI Pediatric; 5 mL vial (NDC 61703-421-53) | Next delivery December Estimated recovery: 1Q 2013 | ||||
Baxter (Infuvite adult and pediatric IV solution) | INFUVITE Pediatric, Multiple Vitamins for Injection. Single Dose package. (NDC 54643-5646-1) | Baxter is the distributor of INFUVITE Multi Vitamins. Baxter has these multi-vitamin products on allocation and is working with the manufacturer to maximize the availability of INFUVITE Multi Vitamins.
Allocated availability through Sept. 2013. | For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition | Requirements related to complying with good manufacturing practices. | Reverified 9/24/2012 |
| INFUVITE Adult, Multiple Vitamins for Injection. Single dose package. (NDC 54643-5649-1) | |||||
| INFUVITE Adult, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5649-2) | |||||
| INFUVITE Pediatric, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5647-0) |
Mustargen (mechlorethamine HCl) injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Lundbeck Inc. Customer service number: 1-888-514-5204 | 10 mg/vial (NDC 67386-911-51) | Lundbeck expects Mustargen to be available again in mid-October 2012. Updates will be provided as they become available. | Please see the Dear Healthcare Professional Letter (PDF - 24KB) from Lundbeck for additional information. | Other | Reverified 10/9/2012 |
Nalbuphine HCl Injection (Initial Posting - 5/15/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 10 mg/mL; 1 mL ampule (NDC 0409-1463-01) | Next delivery January Estimated recovery 2Q 2013 | Please check with your wholesaler for available inventory. Shortage per Manufacturer: | Other | Revised 10/12/2012 |
| 10 mg/mL; 10 mL vial (NDC 0409-1464-01) | Next delivery December/Estimated recovery 1Q 2013 | ||||
| 20 mg/mL; 1 mL ampule (NDC 0409-1465-01) | Next delivery January Estimated recovery 1Q 2013 | ||||
| 20 mg/mL; 10 mL vial (NDC 0409-1467-01) | Next delivery October Estimated recovery 1Q 2013 |
Naloxone Injection (Initial Posting Date) - 2/22/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | Naloxone 0.4 mg/mL Injection; 1mL vial (NDC 00409-1215-01) | Available | Please check with your wholesaler for available inventory.
Shortage per Manufacturer manufacturing delay | Other | Revised 10/12/2012 |
| Naloxone 0.4 mg/mL Injection; 10mL MDV (NDC 00409-1219-01) | Next delivery November Estimated recovery 1Q 2013 | ||||
| Naloxone 0.4 mg/mL Injection; 1mL in 2mL Carpuject (NDC 00409-1782-69) | Next delivery September Estimated recovery February | ||||
| Amphastar Pharmaceuticals, Inc. 1-800-423-4136 | 1mg/mL, 2mL Prefilled Syringe with needles (NDC 76329-1469-5) | Available | Other | Reverified 9/24/2012 | |
| 1mg/mL, 2mL Prefilled Syringe without needles (NDC 76329-3369-1) |
Naltrexone Oral Tablets (Initial Posting Date) - 2/22/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Mallinckrodt Customer Service: 1-800-325-8888 | 50 mg oral tablets 100 count (NDC 00406-1170-01) | Limited availability through Fall 2012. | Shortage per Manufacturer: Raw material supply | Shortage of an active ingredient. | Reverified 10/10/2012 |
| 50 mg oral tablets 30 count (NDC 00406-1170-03) | |||||
Teva Pharmaceuticals | Naltrexone HCl Tablets, 50 mg 30 count (NDC 00555-0902-01) | Both presentations have inventory available. | Revised 10/8/2012 | ||
| Naltrexone HCl Tablets, 50 mg, 100 count (NDC 00555-0902-02) | Both presentations have inventory available. |
Nefazodone Tablets (Initial Posting Date) - 4/16/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals 1-888-838-2872 | 50 mg, 100 count (NDC 00093-7178-01) | Available. Inventory will remain low until 4Q12. | No backorder or future projections of backorder. Improved inventory position expected by Q412. | Shortage of an active ingredient. | Reverified 10/18/2012 |
| 100 mg, 60 count (NDC 00093-1024-06) | Available. Teva supply adequate to meet demand. | ||||
| 150 mg, 60 count (NDC 00093-7113-06) | Available. Inventory will remain low until 4Q12. | ||||
NeoProfen (ibuprofen lysine) Injection (updated 12/15/2011)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Lundbeck Inc. Customer service number: 1-888-514-5204 | 10 mg/mL ibuprofen equivalent, 2mL vial (NDC 67386-0122-52) | Lundbeck anticipates NeoProfen to be available early fourth quarter 2012. | Shortage per Manufacturer: | Other | Reverified 10/10/2012 |
Neurolite, Kit for the Preparation of Technetium Tc99m Bicisate for Injection (Initial Posting Date) – 5/4/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Lantheus Medical Imaging 1-800-299-3431 | 2 kit in 1 package, combination (NDC 11994-006-02) | Lantheus has Neurolite on back order and the company cannot estimate a release date. | Shortage per Manufacturer: Manufacturing delays at contract manufacturer | Requirements related to complying with good manufacturing practices | Reverified 9/26/2012 |
| 5 kit in 1 package, combination (NDC 11994-006-05) |
Nitroglycerin Ointment USP, 2% (Nitro-Bid) 
(Initial posting - 10/23/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Savage Laboratories, A division of Fougera Pharmaceuticals Inc. 1-800-645-9833 | Nitro-Bid | Backorder; estimated release date December 2012 | Shortage per manufacturer; delay in receiving acceptable printed foil | Other | |
Nitro-Bid | Backorder; estimated release date November 2012 | Backorder situation due to demand increase of 1 g foil package | |||
| Nitro-Bid (Nitroglycerin Ointment USP, 2%); 60 g tube (NDC 0281-0326-60) | Available |
Norethindrone and Ethinyl Estradiol Tablets, USP (Ovcon 50 Tablets) (Initial Posting -4/6/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Warner Chilcott Customer Service 1-877-597-9462 | 28x6 (NDC 0430-0585-14) | No estimated date of availability. | Shortage per Manufacturer: Manufacturing delays | Other | |
| 28x3 (NDC 0430-0585-45) |
